TD Asset Management’s Autolus Therapeutics AUTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-98,406
Closed -$357K 1270
2024
Q3
$357K Sell
98,406
-108,642
-52% -$433K ﹤0.01% 1329
2024
Q2
$721K Sell
207,048
-135,358
-40% -$584K ﹤0.01% 1217
2024
Q1
$2.18M Buy
342,406
+207,106
+153% +$1.29M ﹤0.01% 988
2023
Q4
$871K Buy
+135,300
New +$516K ﹤0.01% 1203
2020
Q1
Sell
-17,057
Closed -$225K 1370
2019
Q4
$225K Sell
17,057
-3,072
-15% -$40.2K ﹤0.01% 1356
2019
Q3
$250K Sell
20,129
-1,100
-5% -$14.5K ﹤0.01% 1278
2019
Q2
$342K Buy
21,229
+10,680
+101% +$239K ﹤0.01% 1232
2019
Q1
$332K Buy
10,549
+400
+4% +$11.4K ﹤0.01% 1246
2018
Q4
$333K Buy
10,149
+200
+2% +$6.58K ﹤0.01% 1289
2018
Q3
$300K Buy
9,949
+300
+3% +$8.1K ﹤0.01% 1368
2018
Q2
$258K Buy
+9,649
New +$255K ﹤0.01% 1362

Other funds holding AUTL